FDA Previews Final Drug-Eluting Stent Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA previewed several changes it will make in its final drug-eluting stent guidance at the Transcatheter Cardiovascular Therapeutics symposium in Washington, D.C., on Oct. 15